Protein kinase D in the hypertrophy pathway
Yuan Yan Sin1, George S Baillie
1Molecular Pharmacology Group, Institute of Cardiovascular and Medical Science, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8QQ, UK. y.sin.1@research.gla.ac.uk
Abstract:
Chronic neurohormonal stimulation can have direct adverse effects on the structure and function of the heart. Heart failure develops and progresses as a result of the deleterious changes. It is well established that phosphorylation of class II HDAC5 (histone deacetylase 5) is an important event in the transcriptional regulation of cardiac gene reprogramming that results in the hypertrophic growth response. To date, experimentation on phosphorylation-mediated translocation of HDAC5 has focused on the regulatory properties of PKD (protein kinase D) within intact cells. With regard to the potential role of PKD in myocardium, recent observations raise the possibility that PKD-mediated myocardial regulatory mechanisms may represent promising therapeutic avenues for the treatment of heart failure. The present review summarizes the most recent and important insights into the role of PKD in hypertrophic signalling pathways.
Insights
Protein kinase D (PKD) plays a key role in heart hypertrophy by regulating histone deacetylase 5 (HDAC5) translocation. Understanding this pathway offers potential new treatments for heart failure.
Area of Science:
- Cardiology
- Molecular Biology
- Biochemistry
Background:
- Chronic neurohormonal stimulation adversely affects cardiac structure and function, leading to heart failure.
- Phosphorylation of class II histone deacetylase 5 (HDAC5) is crucial for cardiac gene reprogramming and hypertrophy.
- Protein kinase D (PKD) is implicated in the regulation of HDAC5 translocation.
Purpose of the Study:
- To review recent insights into the role of PKD in cardiac hypertrophic signaling pathways.
- To explore the potential of PKD-mediated mechanisms as therapeutic targets for heart failure.
Main Methods:
- This review summarizes existing experimental findings and recent observations.
- Focuses on the regulatory properties of PKD in HDAC5 phosphorylation and translocation within cardiac cells.
Main Results:
- PKD-mediated regulation of HDAC5 is a significant event in cardiac hypertrophy.
- Recent observations suggest PKD's role in myocardial regulation may offer therapeutic potential.
Conclusions:
- PKD signaling is a critical component of the hypertrophic response in the heart.
- Targeting PKD-mediated pathways presents a promising avenue for developing novel heart failure therapies.
Related Concept Videos
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases
cAMP-dependent Protein Kinase Pathways
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
Receptor Tyrosine Kinases
Protein-protein Interfaces


